Venable FDA Pulse: FDA at the 100-Day Mark of Trump Administration 2.0
By EsqSocial Corporation 30/04/25
Since returning to office for a second term, President Trump has taken steps to reshape federal agencies. Here, we discuss the significant changes that have occurred at the Food and Drug Administration (FDA or Agency) during the first 100 days of the second Trump administration, including (1) the appointment of a new commissioner; (2) changes in FDA leadership; and (3) plans to reorganize the Agency and reduce its workforce....
By: Venable LLP